Status:
COMPLETED
PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis
Lead Sponsor:
Hull University Teaching Hospitals NHS Trust
Conditions:
Inflammatory Bowel Diseases
COVID
Eligibility:
All Genders
16-100 years
Brief Summary
Whether the perceived changes in management of Acute Severe Ulcerative Colitis during the COVID pandemic are widespread, and whether they have any impact on patient outcomes
Detailed Description
The study aims to evaluate the process, evaluation and therapy variation in management of ASUC with reference to 2019 British Society of Gastroenterology guidelines and see whether there are any diffe...
Eligibility Criteria
Inclusion
- Patients aged 16 -100 inclusive
- Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period
Exclusion
- Patients aged 16 -100 inclusive
- Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period
- Admission for elective colectomy
- Pouch or stoma
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04411784
Start Date
May 20 2020
End Date
August 31 2020
Last Update
November 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust
Hull, United Kingdom